SG11201908454TA - Triazole-containing macrolides and ophthalmic uses therefor - Google Patents

Triazole-containing macrolides and ophthalmic uses therefor

Info

Publication number
SG11201908454TA
SG11201908454TA SG11201908454TA SG11201908454TA SG 11201908454T A SG11201908454T A SG 11201908454TA SG 11201908454T A SG11201908454T A SG 11201908454TA SG 11201908454T A SG11201908454T A SG 11201908454TA
Authority
SG
Singapore
Prior art keywords
international
north carolina
applicant
rule
triazole
Prior art date
Application number
Other languages
English (en)
Inventor
Prabhavathi Fernandes
David Eugene Pereira
Sara Wu
Original Assignee
Cempra Pharmaceuticals Inc
Prabhavathi Fernandes
David Eugene Pereira
Sara Wu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cempra Pharmaceuticals Inc, Prabhavathi Fernandes, David Eugene Pereira, Sara Wu filed Critical Cempra Pharmaceuticals Inc
Publication of SG11201908454TA publication Critical patent/SG11201908454TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SG11201908454T 2017-02-17 2018-02-16 Triazole-containing macrolides and ophthalmic uses therefor SG11201908454TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762460143P 2017-02-17 2017-02-17
PCT/US2018/018523 WO2018152424A1 (en) 2017-02-17 2018-02-16 Triazole-containing macrolides and ophthalmic uses therefor

Publications (1)

Publication Number Publication Date
SG11201908454TA true SG11201908454TA (en) 2019-10-30

Family

ID=63169646

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201908454T SG11201908454TA (en) 2017-02-17 2018-02-16 Triazole-containing macrolides and ophthalmic uses therefor

Country Status (8)

Country Link
US (1) US20200009173A1 (ja)
EP (1) EP3582615A1 (ja)
JP (1) JP2020509086A (ja)
AU (1) AU2018220172A1 (ja)
BR (1) BR112019017223A2 (ja)
CA (1) CA3091413A1 (ja)
SG (1) SG11201908454TA (ja)
WO (1) WO2018152424A1 (ja)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US20020009507A1 (en) * 2000-01-19 2002-01-24 Alcon Universal Ltd. Use of polyethoxylated castor oil for the treatment of dry eye
US7795316B1 (en) * 2007-12-19 2010-09-14 Alcon Research, Ltd. Topical ophthalmic compositions containing tobramycin and dexamethasone
WO2010048600A1 (en) * 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
SG192114A1 (en) * 2011-01-26 2013-08-30 Allergan Inc Androgen composition for treating an opthalmic condition
RU2658050C2 (ru) * 2012-03-27 2018-06-19 Семпра Фармасьютикалз, Инк. Парентеральные составы для введения макролидных антибиотиков
CA2908575C (en) * 2013-04-04 2021-11-16 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
WO2015142853A1 (en) * 2014-03-17 2015-09-24 Encompass Development, Inc. Ocular formulations

Also Published As

Publication number Publication date
AU2018220172A1 (en) 2019-10-03
US20200009173A1 (en) 2020-01-09
BR112019017223A2 (pt) 2020-04-14
WO2018152424A1 (en) 2018-08-23
CA3091413A1 (en) 2018-08-23
EP3582615A1 (en) 2019-12-25
JP2020509086A (ja) 2020-03-26

Similar Documents

Publication Publication Date Title
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201907034PA (en) Methods of treating influenza
SG11201811564QA (en) Methods of treating ovarian cancer
SG11201906763RA (en) Pyrrolo [1,2-b] pyridazine derivatives
SG11201811338VA (en) A novel botulinum neurotoxin and its derivatives
SG11201807784SA (en) 3-desoxy derivative and pharmaceutical compositions thereof
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201805940QA (en) Benzopyrazole compounds and analogues thereof
SG11201900844UA (en) Amino pyrimidine ssao inhibitors
SG11201909155VA (en) Ask1 inhibitor compounds and uses thereof
SG11201903155XA (en) Pharmaceutical compounds
SG11201900349VA (en) Somatostatin modulators and uses thereof
SG11201407851RA (en) Synthesis of pyrrolo [2, 3 - b] pyridines
SG11201908512YA (en) Somatostatin modulators and uses thereof
SG11201908326YA (en) Methods of treating neurodegenerative diseases
SG11201811442UA (en) Formulation of a peptide vaccine
SG11201407368VA (en) Drug for preventing and/or treating polycystic kidney disease
SG11201901374WA (en) Antibiotic compounds
SG11201908660RA (en) N-substituted indole derivatives
SG11201900558RA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201900551WA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201908060PA (en) Wound healing medicament
SG11201901986SA (en) Process for the manufacture of a solid pharmaceutical adminstration form
SG11201908603PA (en) Macrocyclic compound and uses thereof
SG11201408240TA (en) Treatment of motor and movement disorder side effects associated with parkinson's disease treatments